Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein biosynthesis, also known as protein synthesis, is a fundamental biological process in all living cells. It refers to the creation of new proteins, balancing the loss of cellular proteins through degradation or export by producing new ones. Proteins are essential for numerous cellular functions, acting as enzymes, structural components, and hormones. Protein biosynthesis occurs in two main stages: transcription (DNA to mRNA) and translation (mRNA to protein). Targeting protein biosynthesis is a valid therapeutic strategy, particularly in the context of bacterial infections, where differences in the prokaryotic and eukaryotic protein synthesis machinery allow for selective inhibition.
Inhibition of ribosomal function or tRNA binding, leading to disruption of polypeptide chain elongation or initiation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Biosynthesis.